Trials / Completed
CompletedNCT07026357
Impact of 3D-planimetry on Optimized Therapeutic Assessment in Complex Benign Esophageal Stenosis
Impact of 3D-planimetry on Optimized Therapeutic Assessment in Complex Benign Esophageal Stenosis; a Prospective Multi-center Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Thomas Seufferlein · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Esophageal stenosis has a high impact on patients quality of live and food intake affecting personal nutrition status and general health. For benign strictures of the esophagus, endoscopic dilatation therapy is recommended by actual guidelines. Since the extent of dilatation is currently directed by endoscopic view and fluoroscopic imaging, patients are exposed to radiation and the determination of the appropriate extent of dilatation is difficult. Therefore, the aim of this study is to compare the effect of 3D-planimetric measurement with current fluoroscopic monitoring on the success of endoscopic esophageal dilatation therapy in patients with benign esophageal stenosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | 3D-planimetric measurement | Esophageal stenosis is evaluated by 3D-planimetric measurement |
| RADIATION | Fluoroscopic control | Fluoroscopic control of dilatation therapy |
| DIAGNOSTIC_TEST | Endoscopic control | Macroscopic endoscopic control of dilatation therapy |
Timeline
- Start date
- 2022-12-28
- Primary completion
- 2024-03-27
- Completion
- 2024-03-27
- First posted
- 2025-06-18
- Last updated
- 2025-06-18
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT07026357. Inclusion in this directory is not an endorsement.